ClinConnect ClinConnect Logo
Search / Trial NCT06479785

Effects of an Educational Intervention Program on Marble Factory Workers

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jun 24, 2024

Trial Information

Current as of April 29, 2025

Completed

Keywords

Lung Function, Ergonomic Hazards, Marble Factory Workers

ClinConnect Summary

This clinical trial is studying how an educational program can help marble factory workers protect themselves from lung diseases caused by dust exposure. Marble cutting can lead to serious health problems like asthma and chronic obstructive pulmonary disease (COPD) because many workers don’t know about the risks and often lack proper safety equipment. The program aims to teach workers about these dangers and how to work safely, which could improve their overall health and reduce issues related to lifting heavy loads and poor posture.

To participate in this study, workers need to be adult males aged between 20 and 55, have been working in a marble factory for at least a year, and work a minimum of 6 hours each day. Unfortunately, workers who already have lung diseases or other health hazards, or those who do not wish to join the study, will not be eligible. Those who participate can expect to learn valuable information that could help them stay healthier on the job. Overall, the findings from this trial could lead to better safety practices in the marble industry, benefiting many workers.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Adult male marble factory workers,
  • Age 20-55years
  • Working for more than 1year
  • Working time(hours): minimum 06 hours daily
  • Exclusion Criteria:
  • Workers with pre-existing lung diseases
  • Workers with any other occupational hazard
  • Workers who are not willing to participate in the study

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Islamabad, Al, Pakistan

Patients applied

0 patients applied

Trial Officials

Suman Sheraz, PhD*

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported